Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population (TORCH)
THE TORCH TRIAL：Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
A PHASE4 clinical study on Symptomatic Aortic Stenosis, this trial is actively recruiting participants. The trial is conducted by Second Affiliated Hospital, School of Medicine, Zhejiang University and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Study Description(click to expand)Subjects enrolled are those who undergo physical exams and screening tests and were classified as a patient with symptomatic aortic stenosis or severe aortic regurgitation. They are then performed transcatheter aortic valve replacement.
Subjects enrolled are those who undergo physical exams and screening tests and were classified as a patient with symptomatic aortic stenosis or severe aortic regurgitation. They are then performed transcatheter aortic valve replacement.
Status Flow
Change History
7 versions recorded-
Jan 2026 — Present [monthly]
Recruiting PHASE4
-
Sep 2024 — Present [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Sep 2021 — Jul 2024 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting · Phase: PHASE3 → PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Second Affiliated Hospital, School of Medicine, Zhejiang University
For direct contact, visit the study record on ClinicalTrials.gov .